vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and BayCom Corp (BCML). Click either name above to swap in a different company.
BayCom Corp is the larger business by last-quarter revenue ($25.9M vs $19.2M, roughly 1.4× Apyx Medical Corp). BayCom Corp runs the higher net margin — 26.5% vs -6.8%, a 33.3% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 9.4%). BayCom Corp produced more free cash flow last quarter ($30.1M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 2.9%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.
APYX vs BCML — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $25.9M |
| Net Profit | $-1.3M | $6.9M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | 36.6% |
| Net Margin | -6.8% | 26.5% |
| Revenue YoY | 34.7% | 9.4% |
| Net Profit YoY | 71.9% | 12.1% |
| EPS (diluted) | — | $0.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $25.9M | ||
| Q3 25 | $12.9M | $25.7M | ||
| Q2 25 | $11.4M | $24.7M | ||
| Q1 25 | $9.4M | $24.3M | ||
| Q4 24 | $14.2M | $23.7M | ||
| Q3 24 | $11.5M | $25.6M | ||
| Q2 24 | $12.1M | $23.8M | ||
| Q1 24 | $10.2M | $24.5M |
| Q4 25 | $-1.3M | $6.9M | ||
| Q3 25 | $-2.0M | $5.0M | ||
| Q2 25 | $-3.8M | $6.4M | ||
| Q1 25 | $-4.2M | $5.7M | ||
| Q4 24 | $-4.6M | $6.1M | ||
| Q3 24 | $-4.7M | $6.0M | ||
| Q2 24 | $-6.6M | $5.6M | ||
| Q1 24 | $-7.6M | $5.9M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | 36.6% | ||
| Q3 25 | -6.5% | 26.3% | ||
| Q2 25 | -22.6% | 35.3% | ||
| Q1 25 | -32.4% | 31.6% | ||
| Q4 24 | -21.4% | 34.2% | ||
| Q3 24 | -31.6% | 32.4% | ||
| Q2 24 | -45.7% | 31.9% | ||
| Q1 24 | -64.6% | 33.3% |
| Q4 25 | -6.8% | 26.5% | ||
| Q3 25 | -15.4% | 19.5% | ||
| Q2 25 | -33.2% | 25.8% | ||
| Q1 25 | -44.0% | 23.4% | ||
| Q4 24 | -32.5% | 25.9% | ||
| Q3 24 | -40.9% | 23.5% | ||
| Q2 24 | -54.0% | 23.6% | ||
| Q1 24 | -74.0% | 24.0% |
| Q4 25 | — | $0.63 | ||
| Q3 25 | — | $0.46 | ||
| Q2 25 | — | $0.58 | ||
| Q1 25 | — | $0.51 | ||
| Q4 24 | — | $0.55 | ||
| Q3 24 | — | $0.54 | ||
| Q2 24 | $-0.19 | $0.50 | ||
| Q1 24 | $-0.22 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | — |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $338.6M |
| Total Assets | $66.8M | $2.6B |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | — | ||
| Q3 25 | $25.1M | — | ||
| Q2 25 | $29.3M | — | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $31.7M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $32.7M | — | ||
| Q1 24 | $37.3M | — |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $338.6M | ||
| Q3 25 | $5.8M | $334.3M | ||
| Q2 25 | $7.3M | $330.6M | ||
| Q1 25 | $10.5M | $329.3M | ||
| Q4 24 | $14.2M | $324.4M | ||
| Q3 24 | $11.0M | $321.7M | ||
| Q2 24 | $14.7M | $315.3M | ||
| Q1 24 | $20.3M | $314.2M |
| Q4 25 | $66.8M | $2.6B | ||
| Q3 25 | $57.4M | $2.6B | ||
| Q2 25 | $58.2M | $2.6B | ||
| Q1 25 | $60.2M | $2.6B | ||
| Q4 24 | $64.8M | $2.7B | ||
| Q3 24 | $60.7M | $2.6B | ||
| Q2 24 | $65.4M | $2.6B | ||
| Q1 24 | $70.7M | $2.6B |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $31.8M |
| Free Cash FlowOCF − Capex | $-2.8M | $30.1M |
| FCF MarginFCF / Revenue | -14.6% | 116.2% |
| Capex IntensityCapex / Revenue | 1.4% | 6.7% |
| Cash ConversionOCF / Net Profit | — | 4.64× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $51.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $31.8M | ||
| Q3 25 | $-3.5M | $7.3M | ||
| Q2 25 | $-1.2M | $6.4M | ||
| Q1 25 | $-702.0K | $9.3M | ||
| Q4 24 | $-2.9M | $30.4M | ||
| Q3 24 | $-4.4M | $9.6M | ||
| Q2 24 | $-4.3M | $7.7M | ||
| Q1 24 | $-6.3M | $5.1M |
| Q4 25 | $-2.8M | $30.1M | ||
| Q3 25 | $-4.1M | $6.2M | ||
| Q2 25 | $-1.5M | $5.6M | ||
| Q1 25 | $-757.0K | $9.1M | ||
| Q4 24 | $-3.2M | $28.7M | ||
| Q3 24 | $-4.6M | $9.4M | ||
| Q2 24 | $-4.6M | $7.4M | ||
| Q1 24 | $-6.4M | $3.9M |
| Q4 25 | -14.6% | 116.2% | ||
| Q3 25 | -31.5% | 24.3% | ||
| Q2 25 | -13.2% | 22.8% | ||
| Q1 25 | -8.0% | 37.6% | ||
| Q4 24 | -22.4% | 121.1% | ||
| Q3 24 | -40.0% | 36.6% | ||
| Q2 24 | -38.0% | 31.2% | ||
| Q1 24 | -62.2% | 16.1% |
| Q4 25 | 1.4% | 6.7% | ||
| Q3 25 | 4.0% | 4.3% | ||
| Q2 25 | 2.3% | 3.0% | ||
| Q1 25 | 0.6% | 0.6% | ||
| Q4 24 | 1.7% | 7.2% | ||
| Q3 24 | 1.3% | 1.0% | ||
| Q2 24 | 2.4% | 1.0% | ||
| Q1 24 | 0.3% | 4.7% |
| Q4 25 | — | 4.64× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | — | 1.00× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 4.96× | ||
| Q3 24 | — | 1.60× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 0.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
